Dialysis Market is expected to reach USD 283.75 billion by 2035

Rising Global Prevalence of Chronic Kidney Disease Is Driving Market Growth

According to Next Move Strategy Consulting, the global Dialysis Market size was valued at USD 130.21 billion in 2025 and is expected to be valued at USD 145.65 billion by the end of 2026. The industry is projected to grow, reaching USD 283.75 billion by 2035, with a CAGR of 6.46% between 2026 and 2035.

Based on our analysis of epidemiological datasets, clinical registry trends, and structured discussions with nephrologists and dialysis center administrators, the increasing global prevalence of chronic kidney disease (CKD) is emerging as a key factor driving market demand. As CKD progresses to end-stage renal disease (ESRD), a condition in which the kidneys lose their ability to effectively filter blood, dialysis becomes an essential life-sustaining treatment. Healthcare professionals consistently indicate that the growing incidence of diabetes, hypertension, obesity, and ageing populations is steadily expanding the ESRD patient pool, thereby reinforcing long-term demand for dialysis treatment across both developed and developing healthcare systems.

In addition, improvements in disease awareness and the wider adoption of early-stage screening programs are enabling more patients to be diagnosed and monitored before reaching advanced renal failure. Earlier detection, together with the gradual expansion of healthcare infrastructure in emerging economies, is increasing the number of patients eligible for regular dialysis therapy in both in-center and home-based care settings. As a result, the rising clinical burden of CKD is intensifying the need for scalable, efficient, and patient-centric dialysis solutions, which is expected to support sustained market growth. 

However, based on our evaluation, the high cost of dialysis equipment and services restrains market growth, particularly in low- and middle-income countries. While technological innovations have improved accessibility and treatment quality, the financial burden of purchasing, operating, and maintaining advanced systems remains significant. Expenses related to machines, consumables, infrastructure, and ongoing maintenance place pressure on healthcare systems and patients, limiting access to care in underserved areas and slowing global market expansion.

On the other hand, we observed that the integration of artificial intelligence (AI) and machine learning (ML) drives new opportunities in kidney care. Our analysis of National Institutes of Health research indicates that AI and ML enhance clinical decision-making across hemodialysis, peritoneal dialysis, and kidney transplantation. 

These technologies improve predictions of dialysis adequacy, cardiovascular risks, and infection likelihood, while enabling personalised treatment plans. By leveraging large volumes of patient data, AI-driven tools optimise workflows and support early interventions, which improve outcomes and reduce costs. Based on our assessment, digital transformation driven by AI and ML expands market potential and improves global kidney care.

Request for a Sample PDF of the Dialysis Market Report

The dialysis industry comprises a mix of global healthcare leaders and specialized renal care providers that actively contribute to technological development and service expansion. Key participants operating in the market include Fresenius Medical Care, DaVita Inc., Vantive, U.S. Renal Care, Inc., Diaverum Deutschland GmbH, Nipro Corporation, B. Braun Melsungen AG, Asahi Kasei Corporation, Becton, Dickinson and Company, Nikkiso Co., Ltd., Toray Medical Co., Ltd., Outset Medical, Inc., Terumo Corporation, Teleflex, W. L. Gore & Associates, Inc., Apollo Hospitals Enterprise Ltd, Dialife SA, and Others. These companies compete across dialysis equipment manufacturing, consumables, and dialysis service networks, contributing to ongoing innovation and expansion of renal care infrastructure worldwide.

Several strategic developments by key industry participants are shaping the competitive and technological landscape of the dialysis market share. In September 2025, Outset Medical entered into a partnership with Northwest Kidney Centers to integrate its Tablo Hemodialysis System into Northwest Kidney Centers’ home dialysis programs. This collaboration aims to expand patient access to flexible, home-based dialysis solutions and improve treatment convenience for individuals requiring long-term renal care.

Earlier, in June 2025, Fresenius Medical Care announced a USD 1.06 billion share buyback program as part of its strategic transformation initiative, FME Reignite Strategy. Through this initiative, the company also outlined more ambitious profitability targets, aiming to achieve mid-teens operating margins by 2030 as it strengthens operational efficiency and focuses on core dialysis services.

In October 2024, Fresenius Medical Care received clearance from the U.S. Food and Drug Administration under the 510(k) pathway for its 5008X Hemodialysis System, a high-volume hemodiafiltration (HDF) device designed to enhance dialysis performance and patient outcomes. Following the regulatory approval, the company has been preparing for a broader commercial rollout of the system in 2025, reinforcing its position in advanced dialysis technology. 

Key Insights from the Dialysis Market Report:

• The information related to key drivers, restraints, and opportunities and their impact on the dialysis market growth is provided in the report.

• The value chain analysis in the market study provides a clear picture of the role of each stakeholder.

• The market share of the global dialysis market players and their competitive analysis are provided in the report.